8 reports of this reaction
1.9% of all FLUPHENAZINE HYDROCHLORIDE reports
#17 most reported adverse reaction
SUICIDAL IDEATION is the #17 most commonly reported adverse reaction for FLUPHENAZINE HYDROCHLORIDE, manufactured by Rising Pharma Holdings, Inc.. There are 8 FDA adverse event reports linking FLUPHENAZINE HYDROCHLORIDE to SUICIDAL IDEATION. This represents approximately 1.9% of all 426 adverse event reports for this drug.
Patients taking FLUPHENAZINE HYDROCHLORIDE who experience suicidal ideation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SUICIDAL IDEATION is a less commonly reported adverse event for FLUPHENAZINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to suicidal ideation, the following adverse reactions have been reported for FLUPHENAZINE HYDROCHLORIDE:
The following drugs have also been linked to suicidal ideation in FDA adverse event reports:
SUICIDAL IDEATION has been reported as an adverse event in 8 FDA reports for FLUPHENAZINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
SUICIDAL IDEATION accounts for approximately 1.9% of all adverse event reports for FLUPHENAZINE HYDROCHLORIDE, making it a notable side effect.
If you experience suicidal ideation while taking FLUPHENAZINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.